RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus.
A novel intrinsic HIV-1 antisense gene was previously described with RNA initiating from the region of an HIV-1 antisense initiator promoter element (HIVaINR). The antisense RNA is exactly complementary to HIV-1 sense RNA and capable of forming approximately 400 base-pair (bp) duplex RNA in the region of the long terminal repeat (LTR) spanning the beginning portion of TAR in the repeat (R) region and extending through the U3 region. Duplex or double-stranded RNA of several hundred nucleotides in length is a key initiating element of RNA interference (RNAi) in several species. This HIVaINR antisense RNA is also capable of forming multiple stem-loop or hairpin-like secondary structures by M-fold analysis, with at least one that perfectly fits the criteria for a microRNA (miRNA) precursor. MicroRNAs (miRNAs) interact in a sequence-specific manner with target messenger RNAs (mRNAs) to induce either cleavage of the message or impede translation. Human mRNA targets of the predicted HIVaINR antisense RNA (HAA) microRNAs include mRNA for the human interleukin-2 receptor gamma chain (IL-2RG), also called the common gamma (gammac) receptor chain, because it is an integral part of 6 receptors mediating interleukin signalling (IL-2R, IL-4R, IL-7R, IL-9R, IL-15R and IL-21R). Other potential human mRNA targets include interleukin-15 (IL-15) mRNA, the fragile x mental retardation protein (FMRP) mRNA, and the IL-1 receptor-associated kinase 1 (IRAK1) mRNA, amongst others. Thus the proposed intrinsic HIVaINR antisense RNA microRNAs (HAAmiRNAs) of the human immunodeficiency virus form complementary targets with mRNAs of a key human gene in adaptive immunity, the IL-2Rgammac, in which genetic defects are known to cause an X-linked severe combined immunodeficiency syndrome (X-SCID), as well as mRNAs of genes important in innate immunity. A new model of intrinsic RNA silencing induced by the HIVaINR antisense RNA in the absence of Tat is proposed, with elements suggestive of both small interfering RNA (siRNA) and miRNA.
Ludwig
Linda B
LB
linda.b.ludwig@gmail.com
D049109:Cell Proliferation; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D006678:HIV / Q000737:chemistry / Q000235:genetics*; D054884:Host-Pathogen Interactions; D006801:Humans; D053631:Interleukin Receptor Common gamma Subunit / Q000235:genetics; D053592:Interleukin-1 Receptor-Associated Kinases / Q000235:genetics; D019409:Interleukin-15 / Q000235:genetics; D035683:MicroRNAs / Q000737:chemistry / Q000235:genetics; D008957:Models, Genetic; D034622:RNA Interference; D016372:RNA, Antisense / Q000737:chemistry / Q000235:genetics; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics; D013601:T-Lymphocytes / Q000502:physiology / Q000821:virology; D053632:X-Linked Combined Immunodeficiency Diseases / Q000209:etiology / Q000821:virology*
D051860:Fragile X Messenger Ribonucleoprotein 1; D053631:Interleukin Receptor Common gamma Subunit; D053592:Interleukin-1 Receptor-Associated Kinases; D019409:Interleukin-15; D035683:MicroRNAs; D016372:RNA, Antisense; D012367:RNA, Viral; C497683:FMR1 protein, human; C507768:IRAK1 protein, human
EMBO Rep. 2005 Oct;6(10):961-7
16142218
Science. 1993 Dec 17;262(5141):1877-80
8266077
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
16885212
Retrovirology. 2007 Jan 25;4:5
17442096
Mol Cells. 2005 Feb 28;19(1):1-15
15750334
Cell. 1993 Apr 9;73(1):147-57
8462096
Nature. 2005 Feb 17;433(7027):769-73
15685193
Genes Dev. 2001 Jan 15;15(2):188-200
11157775
Immunity. 2005 May;22(5):607-19
15894278
Nucleic Acids Res. 2005 Feb 01;33(2):796-804
15687388
Science. 2007 Mar 16;315(5818):1579-82
17322031
Neuroscience. 2003;120(4):1005-17
12927206
Nature. 2001 Jan 18;409(6818):363-6
11201747
Mol Cell. 2004 Jul 23;15(2):185-97
15260970
EMBO J. 2002 Sep 2;21(17):4663-70
12198168
Curr Opin Struct Biol. 2005 Jun;15(3):331-41
15925505
Neuron. 2003 Feb 6;37(3):417-31
12575950
Nature. 2000 Mar 16;404(6775):293-6
10749213
Genes Dev. 2002 Mar 15;16(6):720-8
11914277
PLoS Biol. 2004 Nov;2(11):e363
15502875
Science. 2001 Oct 26;294(5543):862-4
11679672
Science. 1991 Mar 29;251(5001):1597-600
2011739
Genes Dev. 2002 Oct 1;16(19):2497-508
12368261
Nature. 2000 Feb 24;403(6772):901-6
10706289
J Biol Chem. 2002 Apr 5;277(14):12047-52
11815609
Nature. 2003 Sep 25;425(6956):411-4
14508492
J Immunol. 2005 Feb 1;174(3):1213-21
15661875
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W577-81
15980540
Nat Neurosci. 2004 Feb;7(2):113-7
14703574
Science. 1994 Nov 11;266(5187):1042-5
7973658
EMBO J. 2005 Jan 12;24(1):138-48
15565168
Curr Biol. 2003 Jan 8;13(1):41-6
12526743
Genes Dev. 2003 Feb 15;17(4):438-42
12600936
Retrovirology. 2004 Dec 15;1:43
15601472
Curr Biol. 2004 Dec 14;14(23):2162-7
15589161
EMBO J. 1994 Jun 15;13(12):2822-30
8026467
Science. 1995 Nov 10;270(5238):988-91
7481804
Curr Biol. 2005 Jun 21;15(12):R458-60
15964265
Retrovirology. 2004 Dec 15;1:44
15601474
Nucleic Acids Res. 2004 Sep 08;32(16):4776-85
15356295
Blood. 2001 Aug 1;98(3):877-9
11468191
Cell. 2006 Jun 2;125(5):887-901
16751099
EMBO J. 2001 Dec 3;20(23):6877-88
11726523
Nature. 2000 Nov 2;408(6808):86-9
11081512
Science. 1993 Dec 17;262(5141):1880-3
8266078
Nat Struct Mol Biol. 2004 Mar;11(3):214-8
14983173
Nature. 2001 Jun 14;411(6839):834-42
11459066
J Virol. 1992 Jul;66(7):4488-96
1602555
Science. 2001 Oct 26;294(5543):853-8
11679670
Cell. 2000 May 26;101(5):533-42
10850495
Genes Dev. 2004 Mar 1;18(5):504-11
15014042
Cell. 1993 Dec 3;75(5):843-54
8252621
Immunity. 1998 Nov;9(5):669-76
9846488
Proc IEEE Comput Soc Bioinform Conf. 2003;2:159-68
16452790
Genes Dev. 2002 Nov 1;16(21):2733-42
12414724
J Biol Chem. 2003 Nov 7;278(45):44312-9
12952966
Neuron. 2003 Feb 20;37(4):555-8
12597853
Cell. 1993 Dec 3;75(5):855-62
8252622
Cell. 2002 Sep 6;110(5):563-74
12230974
J Mol Biol. 1999 May 21;288(5):911-40
10329189
Dev Biol. 1999 Dec 15;216(2):671-80
10642801
Cell. 2005 Jul 15;122(1):6-7
16009126
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
12824337
J Exp Med. 1995 Apr 1;181(4):1519-26
7699333
Nature. 2003 Dec 18;426(6968):874-8
14661029
Nature. 1987 Apr 16-22;326(6114):711-3
3031512
RNA. 2007 Apr;13(4):457-62
17299129
Science. 2001 Oct 26;294(5543):858-62
11679671
Nucleic Acids Res. 2003 Nov 15;31(22):6593-7
14602919
Nature. 2000 Nov 2;408(6808):57-63
11081504
J Biol Chem. 2005 Jul 29;280(30):27595-603
15932881
Science. 2004 Jan 2;303(5654):95-8
14631048
Genes Dev. 1990 Dec;4(12A):2061-74
2269426
Retrovirology. 2007 Oct 15;4:74
17937800
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13959-64
9811908
Virus Res. 2004 Jun 1;102(1):97-108
15068885
J Immunol. 2002 Oct 1;169(7):3600-5
12244150
Am J Hum Genet. 1995 Sep;57(3):564-71
7668284
Cell. 1985 Jul;41(3):813-23
2988790
Hum Mol Genet. 1993 Aug;2(8):1099-104
8401490
Annu Rev Biochem. 1986;55:569-97
2427015
Retrovirology. 2006 Nov 08;3:80
17090330
Scand J Immunol. 2001 Dec;54(6):582-91
11902333
J Exp Med. 2000 Mar 6;191(5):771-80
10704459
Nat Struct Mol Biol. 2005 Apr;12(4):340-9
15800637
Genes Dev. 2002 Oct 1;16(19):2491-6
12368260
Immunol Lett. 2007 Nov 30;114(1):1-8
17936914
Nature. 2003 Sep 25;425(6956):415-9
14508493
Nature. 2005 Aug 4;436(7051):740-4
15973356
Cell. 2003 Dec 26;115(7):787-98
14697198
Cell. 2001 Nov 16;107(4):477-87
11719188
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5000-4
2425359
Genes Dev. 2004 Dec 15;18(24):3016-27
15574589
IEEE/ACM Trans Comput Biol Bioinform. 2004 Jan-Mar;1(1):53-62
17048408
Retrovirology. 2007 Nov 24;4:82
18036240
Science. 2004 Sep 3;305(5689):1437-41
15284456
Genes Dev. 2003 Dec 15;17(24):3011-6
14681208
Cell. 2004 Jul 9;118(1):57-68
15242644
Trends Genet. 2001 Aug;17(8):449-59
11485817
Cell. 2004 Jan 23;116(2):281-97
14744438
Immunity. 1997 Jul;7(1):1-11
9252115
BMC Mol Biol. 2007 Jul 30;8:63
17663774
Nature. 2004 Sep 16;431(7006):343-9
15372041
Science. 2001 Aug 3;293(5531):834-8
11452083
Nucleic Acids Res. 2008 Apr;36(7):2353-65
18299284